Iovance Biotherapeutics Inc (IOVA)

Dec 21, 2024

Barclays PLC Raises Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 21, 2024

Dec 21, 2024

Where are the Opportunities in (IOVA) - Stock Traders Daily

Dec 21, 2024

Dec 20, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Dec 20, 2024

Dec 20, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire Inc.

Dec 20, 2024

Dec 19, 2024

Insiders' US$48.3m Investments In Red Following Iovance Biotherapeutics' US$402m Dip In Market Value - Simply Wall St

Dec 19, 2024

Dec 17, 2024

KEI Comments on NIH Exclusive License to Iovance for T-cell Vaccine for Cancer Treatment - Knowledge Ecology International

Dec 17, 2024

Dec 16, 2024

Iovance Biotherapeutics: Amtagvi Launch Growing, But Stock Isn't (NASDAQ:IOVA) - Seeking Alpha

Dec 16, 2024

Dec 16, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Sees Significant Increase in Short Interest - MarketBeat

Dec 16, 2024

Dec 15, 2024

State Street Corp Grows Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 15, 2024

Dec 13, 2024

Iovance Biotherapeutics' SWOT analysis: promising TIL therapy stock faces growth hurdles - Investing.com India

Dec 13, 2024

Dec 12, 2024

Interesting IOVA Call Options For January 2025 - Nasdaq

Dec 12, 2024

Dec 12, 2024

Prediction: This Stock Will Beat the Market in 2025 - Yahoo Finance

Dec 12, 2024

Dec 11, 2024

BNP Paribas Financial Markets Trims Stock Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 11, 2024

Dec 09, 2024

Iovance Biotherapeutics' SWOT analysis: stock shows promise amid challenges By Investing.com - Investing.com Nigeria

Dec 09, 2024

Dec 09, 2024

Iovance Biotherapeutics: Steady Progress (NASDAQ:IOVA) - Seeking Alpha

Dec 09, 2024

Dec 08, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 08, 2024

Dec 07, 2024

Charles Schwab Investment Management Inc. Has $17.96 Million Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 07, 2024

Dec 06, 2024

Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates - MSN

Dec 06, 2024

Dec 03, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63% - Yahoo Finance

Dec 03, 2024

Nov 30, 2024

Braidwell LP Has $2.05 Million Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Nov 30, 2024

Nov 29, 2024

(IOVA) On The My Stocks Page - Stock Traders Daily

Nov 29, 2024

Nov 29, 2024

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect - MSN

Nov 29, 2024

Nov 29, 2024

Intech Investment Management LLC Makes New $920,000 Investment in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Nov 29, 2024

Nov 28, 2024

IOVAIovance Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 28, 2024

Nov 27, 2024

Is Iovance Biotherapeutics Stock a Millionaire Maker? - MSN

Nov 27, 2024

Nov 26, 2024

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

Iovance Biotherapeutics (STU:2LB) Operating Cash Flow per S - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

Iovance Biotherapeutics (NASDAQ:IOVA) delivers shareholders favorable 68% return over 1 year, surging 10.0% in the last week alone - Simply Wall St

Nov 26, 2024

Nov 26, 2024

IOVA (Iovance Biotherapeutics) Total Assets : $991.12 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

Victory Capital Management Inc. Buys 115,387 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Nov 26, 2024

Nov 25, 2024

IOVA (Iovance Biotherapeutics) Cash Flow from Financing : $389.32 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 24, 2024

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back - MSN

Nov 24, 2024

Nov 24, 2024

Landscape Capital Management L.L.C. Takes $615,000 Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Nov 24, 2024

Nov 24, 2024

Eagle Asset Management Inc. Lowers Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Nov 24, 2024

Nov 23, 2024

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 23, 2024

Nov 22, 2024

10 Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 22, 2024

Nov 22, 2024

2 Innovative Stocks That Could Deliver Outsize Returns - Yahoo Finance

Nov 22, 2024

Nov 22, 2024

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey

Nov 22, 2024

Nov 21, 2024

Iovance Biotherapeutics (STU:2LB) Shares Outstanding (EOP) : 304.62 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 19, 2024

Long Term Trading Analysis for (IOVA) - Stock Traders Daily

Nov 19, 2024

Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Iovance Bioth - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Iovance Biotherapeutics director Maynard sells $503k in stock - Investing.com

Nov 14, 2024

Nov 14, 2024

IOVA (Iovance Biotherapeutics) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 13, 2024

Nov 12, 2024

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Principal Financial Group Inc. - MarketBeat

Nov 12, 2024

Nov 11, 2024

Iovance Biotherapeutics Q3: A Beat, But A SelloffNow A Buy Opportunity - Seeking Alpha

Nov 11, 2024

Nov 11, 2024

HC Wainwright Has Positive Outlook for IOVA FY2027 Earnings - MarketBeat

Nov 11, 2024